News
· 11hSerena Williams Lost 31 Pounds on GLP-1 Drug Zepbound: What to Know
Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis legend shared the weight loss medication along with regular exercise and a healthy diet helped her lose 31 pounds.
· 1dSerena Williams under fire: Jameela Jamil challenges her endorsement of GLP-1 weight loss drug
Jameela Jamil has given her two cents on Serena Williams’ endorsement of the GLP-1 weight loss drug. On August 21, 2025, the tennis legend, in an Interview with PEOPLE, revealed that she had recently used the GLP-1 weight loss drug and lost about 31 pounds.
· 18h“Mind your business”: Jameela Jamil calls out Serena Williams for promoting GLP-1 weight loss drug
Serena Williams sparked a heated debate after revealing she lost 31 pounds using a GLP-1 drug. While the tennis legend praised the medication for helping her reach her postpartum goals, actress Jameela Jamil quickly pushed back, warning fans about the drug’s “devastating” risks and questioning the ethics of celebrity endorsements.
Using GLP-1 drugs for weight loss is considered safe but can come with a loss of lean muscle mass. It’s crucial to do ...
One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?
About 12% of all U.S. adults have already tried using GLP-1 agonist drugs to control their weight, according to a survey ...
A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.
Eli Lilly and Novo Nordisk already make popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...
WISH-TV on MSN11h
FDA-approved semaglutide aids weight loss and health conditions
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
Employers and benefits advisors are facing a growing challenge: How to offer access to these high-demand, life-changing ...
The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback